Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Silo Pharma
AddedFeb 19, 2024
UpdatedJun 18, 2026
Silo Pharma

Silo Pharma

Public

Silo Pharma: Pioneering psychedelic medicine in biopharmaceuticals since 2010.

HQ
Englewood Cliffs, NJ, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Silo Pharma Inc. is a developmental stage biopharmaceutical company founded in 2010 and headquartered in Englewood Cliffs, New Jersey. The company specializes in merging traditional therapeutics with psychedelic research to develop novel treatments for underserved conditions such as PTSD, stress-induced psychiatric disorders, chronic pain conditions, and central nervous system diseases. Silo Pharma focuses on acquiring and licensing technology rights and intellectual property from leading universities and researchers to advance its mission.

Silo Pharma has made significant strides in the biopharmaceutical industry by pioneering the integration of psychedelic medicine into traditional therapeutic frameworks. The company's innovative approach has garnered attention and support from key stakeholders in the medical and scientific communities. By addressing critical gaps in treatment for various psychiatric and CNS disorders, Silo Pharma aims to improve patient outcomes and contribute to the evolving landscape of mental health and pain management therapies.

Silo Pharma - Similar Companies

Reset Pharmaceuticals logo

Reset Pharmaceuticals

Seelos Therapeutics logo

Seelos Therapeutics

PleoPharma logo

PleoPharma

pleopharma.com

Psy Therapeutics logo

Psy Therapeutics

psythx.com

Lykos Therapeutics logo

Lykos Therapeutics

lykospbc.com

Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Psylin Neurosciences logo

Psylin Neurosciences

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Sensorium Therapeutics logo

Sensorium Therapeutics

sensorium.bio

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

Psilera logo

Psilera

psilera.com

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

jazzpharma.com

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Resilience Therapeutics logo

Resilience Therapeutics

Siolta Therapeutics logo

Siolta Therapeutics

Silo Pharma - Quick Facts

Who are Silo Pharma's competitors?

Companies similar to Silo Pharma include Reset Pharmaceuticals, Seelos Therapeutics, PleoPharma and Psy Therapeutics.

When was Silo Pharma founded?

Silo Pharma was founded in 2010.

Where is Silo Pharma's headquarters located?

Silo Pharma's headquarters is located in Englewood Cliffs, NJ, US.

How much has Silo Pharma raised to-date?

As of Sep 27, 2022, Silo Pharma has raised a total of $3.4M (USD).

How many employees does Silo Pharma have?

Silo Pharma has 7 employees as of Feb 6, 2024.

Silo Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Healthtech
Unique IDs
  • ein: 462137136
  • secCik: 0001514183
  • ticker: SILO
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2300Apparel And Other Finished Products Made From Fabrics And Similar Material
ISIC
  • 6492Other credit granting
  • 6499Other financial service activities, except insurance and pension funding activities, n.e.c.
Show 33 more industry codes
NAICS
  • 423000Merchant Wholesalers, Durable Goods
  • 423900Miscellaneous Durable Goods Merchant Wholesalers
  • 423940Jewelry, Watch, Precious Stone, and Precious Metal Merchant Wholesalers
  • 425000Wholesale Trade Agents and Brokers
  • 425120Wholesale Trade Agents and Brokers
  • 458000Clothing, Clothing Accessories, Shoe, and Jewelry Retailers
  • 458300Jewelry, Luggage, and Leather Goods Retailers
  • 458310Jewelry Retailers
  • 522200Nondepository Credit Intermediation
  • 522220Sales Financing
  • 522290Other Nondepository Credit Intermediation
  • 522292Real Estate Credit
  • 522299International, Secondary Market, and All Other Nondepository Credit Intermediation
  • 420000Wholesale Trade
  • 450000Retail Trade
  • 520000Finance and Insurance
  • 620000Health Care and Social Assistance
  • 522000Credit Intermediation and Related Activities
  • 623000Nursing and Residential Care Facilities
  • 425100Wholesale Trade Agents and Brokers
SIC
  • 5090Miscellaneous Durable Goods
  • 5094Jewelry, Watches, Precious Stones, and Precious Metals
  • 6100Nondepository Credit Institutions
  • 6150Business Credit Institutions
  • 6159Miscellaneous Business Credit Institutions
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified